Status:

NOT_YET_RECRUITING

Visual Acuity Outcome Differences Between the Alcon Vivity Toric IOL and RxSight LAL+

Lead Sponsor:

The Eye Associates

Conditions:

Cataract

Eligibility:

All Genders

45+ years

Phase:

NA

Brief Summary

Phase 1 will be ambispective, multi-site, single arm study in age-related cataract patients with regular astigmatism, who were bilaterally treated with the LAL+ IOLs Phase 2 will be a prospective, ra...

Eligibility Criteria

Inclusion

  • Adult (≥45) subjects who are astigmatic and require bilateral, routine small-incision, surgery for age-related cataracts with femtosecond laser;
  • All subjects will be required to be targeted for refractive emmetropia (plano or first minus closest to plano);
  • Subjects will have an expected monocular BCDVA outcomes of 20/25 or better in the opinion of the investigator;
  • Subjects will have regular corneal astigmatism (1.00 to 2.00 D), which can be corrected with a toric power IOL of T3-T5;
  • Subjects will be required to have a dilated pupil diameter of 7 mm or greater in both eyes;

Exclusion

  • Moderate-severe corneal pathology;
  • Irregular astigmatism;
  • Subject desire monovision correction;
  • Preexisting macular disease or other retinal degenerative diseases that is expected to cause future vision loss;
  • History of glaucoma;
  • Severe dry eye disease;
  • History of uveitis;
  • History of ocular herpes simplex virus;
  • History of nystagmus;
  • Zonular laxity or dehiscence;
  • History psueudoexfoliation;
  • History of corneal refractive and intraocular surgery or requiring any other planned ocular surgical procedures;
  • Currently taking systemic medication that may increase sensitivity to UV light or that may cause toxicity to the retina;
  • Pregnant or breastfeeding.

Key Trial Info

Start Date :

October 15 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2026

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT06574646

Start Date

October 15 2024

End Date

August 1 2026

Last Update

August 28 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Eye Associates of Manatee, LLP

Bradenton, Florida, United States, 34209

Visual Acuity Outcome Differences Between the Alcon Vivity Toric IOL and RxSight LAL+ | DecenTrialz